docetaxel anhydrous has been researched along with acridine orange in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (acridine orange) | Trials (acridine orange) | Recent Studies (post-2010) (acridine orange) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 2,310 | 19 | 343 |
| Protein | Taxonomy | docetaxel anhydrous (IC50) | acridine orange (IC50) |
|---|---|---|---|
| Amyloid-beta precursor protein | Homo sapiens (human) | 0.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goel, PN; Gude, RP; Manjappa, AS; Ramachandra Murthy, RS | 1 |
1 other study(ies) available for docetaxel anhydrous and acridine orange
| Article | Year |
|---|---|
Anti-neuropilin 1 antibody Fab' fragment conjugated liposomal docetaxel for active targeting of tumours.
Topics: Acridine Orange; Animals; Antineoplastic Agents; Apoptosis; Biological Transport; Cell Line, Tumor; Docetaxel; Drug Carriers; Drug Delivery Systems; Ethidium; Female; Humans; Immunoglobulin Fab Fragments; Liposomes; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Neuropilin-1; Polyethylene Glycols; Staining and Labeling; Taxoids | 2014 |